NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia

Despite improvements in treatment results for pediatric T-cell acute lymphoblastic leukemia, approximately 20% of patients relapse with dismal prognosis. PTEN inactivation and NOTCH1 activation are known frequent leukemogenic events but their effect on outcome is still controversial. We analyzed the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bandapalli, Obul Reddy (VerfasserIn) , Zimmermann, Martin (VerfasserIn) , Kox, Corinne (VerfasserIn) , Stanulla, Martin (VerfasserIn) , Schrappe, Martin (VerfasserIn) , Ludwig, Wolf-Dieter (VerfasserIn) , Köhler, Rolf (VerfasserIn) , Muckenthaler, Martina (VerfasserIn) , Kulozik, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2013
In: Haematologica, the hematology journal
Year: 2013, Jahrgang: 98, Heft: 6, Pages: 928-936
ISSN:1592-8721
DOI:10.3324/haematol.2012.073585
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3324/haematol.2012.073585
Verlag, lizenzpflichtig, Volltext: https://haematologica.org/article/view/6695
Volltext
Verfasserangaben:Obul R. Bandapalli, Martin Zimmermann, Corinne Kox, Martin Stanulla, Martin Schrappe, Wolf-Dieter Ludwig, Rolf Koehler, Martina U. Muckenthaler, and Andreas E. Kulozik

MARC

LEADER 00000caa a2200000 c 4500
001 1736893807
003 DE-627
005 20220819004841.0
007 cr uuu---uuuuu
008 201028s2013 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2012.073585  |2 doi 
035 |a (DE-627)1736893807 
035 |a (DE-599)KXP1736893807 
035 |a (OCoLC)1341375070 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bandapalli, Obul Reddy  |d 1977-  |e VerfasserIn  |0 (DE-588)13397121X  |0 (DE-627)559235070  |0 (DE-576)30022544X  |4 aut 
245 1 0 |a NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia  |c Obul R. Bandapalli, Martin Zimmermann, Corinne Kox, Martin Stanulla, Martin Schrappe, Wolf-Dieter Ludwig, Rolf Koehler, Martina U. Muckenthaler, and Andreas E. Kulozik 
264 1 |c 2013 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.10.2020 
520 |a Despite improvements in treatment results for pediatric T-cell acute lymphoblastic leukemia, approximately 20% of patients relapse with dismal prognosis. PTEN inactivation and NOTCH1 activation are known frequent leukemogenic events but their effect on outcome is still controversial. We analyzed the effect of PTEN inactivation and its interaction with NOTCH1 activation on treatment response and long-term outcome in 301 ALL-BFM treated children with T-cell acute lymphoblastic leukemia. We identified PTEN mutations in 52 of 301 (17.3%) of patients. In univariate analyses this was significantly associated with increased resistance to induction chemotherapy and a trend towards poor long-term outcome. By contrast, patients with inactivating PTEN and activating NOTCH1 mutations showed marked sensitivity to induction treatment and excellent long-term outcome, which was similar to patients with NOTCH1 mutations only, and more favorable than in patients with PTEN mutations only. Notably, in the subgroup of patients with a prednisone- and minimal residual disease (MRD)-response based medium risk profile, PTEN-mutations without co-existing NOTCH1-mutations represented an MRD-independent highly significant high-risk biomarker. Mutations of PTEN highly significantly indicate a poor prognosis in T-ALL patients who have been stratified to the medium risk group of the BFM-protocol. This effect is clinically neutralized by NOTCH1 mutations. Although these results have not yet been explained by an obvious molecular mechanism, they contribute to the development of new molecularly defined stratification algorithms. Furthermore, these data have unexpected potential implications for the development of NOTCH1 inhibitors in the treatment of T-cell acute lymphoblastic leukemia in general, and in those with a combination of PTEN and NOTCH1 mutations in particular. 
700 1 |a Zimmermann, Martin  |e VerfasserIn  |4 aut 
700 1 |a Kox, Corinne  |e VerfasserIn  |0 (DE-588)142786187  |0 (DE-627)640123791  |0 (DE-576)333385128  |4 aut 
700 1 |a Stanulla, Martin  |d 1965-  |e VerfasserIn  |0 (DE-588)141246693  |0 (DE-627)625828917  |0 (DE-576)322976782  |4 aut 
700 1 |a Schrappe, Martin  |d 1958-  |e VerfasserIn  |0 (DE-588)130458805  |0 (DE-627)501601678  |0 (DE-576)298208423  |4 aut 
700 1 |a Ludwig, Wolf-Dieter  |d 1952-  |e VerfasserIn  |0 (DE-588)140336788  |0 (DE-627)617705488  |0 (DE-576)316480525  |4 aut 
700 1 |a Köhler, Rolf  |d 1966-  |e VerfasserIn  |0 (DE-588)12289751X  |0 (DE-627)082221545  |0 (DE-576)293468427  |4 aut 
700 1 |a Muckenthaler, Martina  |e VerfasserIn  |0 (DE-588)1046124595  |0 (DE-627)775766496  |0 (DE-576)173146813  |4 aut 
700 1 |a Kulozik, Andreas  |d 1959-  |e VerfasserIn  |0 (DE-588)1025736567  |0 (DE-627)723892032  |0 (DE-576)167091638  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica, the hematology journal  |d Pavia : Ferrata Storti Foundation, 2005  |g 98(2013), 6, Seite 928-936  |h Online-Ressource  |w (DE-627)48524375X  |w (DE-600)2186022-1  |w (DE-576)414771095  |x 1592-8721  |7 nnas  |a NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia 
773 1 8 |g volume:98  |g year:2013  |g number:6  |g pages:928-936  |g extent:9  |a NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia 
856 4 0 |u https://doi.org/10.3324/haematol.2012.073585  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://haematologica.org/article/view/6695  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201028 
993 |a Article 
994 |a 2013 
998 |g 1025736567  |a Kulozik, Andreas  |m 1025736567:Kulozik, Andreas  |d 910000  |d 910500  |e 910000PK1025736567  |e 910500PK1025736567  |k 0/910000/  |k 1/910000/910500/  |p 9  |y j 
998 |g 1046124595  |a Muckenthaler, Martina  |m 1046124595:Muckenthaler, Martina  |d 910000  |d 910500  |e 910000PM1046124595  |e 910500PM1046124595  |k 0/910000/  |k 1/910000/910500/  |p 8 
998 |g 12289751X  |a Köhler, Rolf  |m 12289751X:Köhler, Rolf  |d 910000  |d 911500  |e 910000PK12289751X  |e 911500PK12289751X  |k 0/910000/  |k 1/910000/911500/  |p 7 
998 |g 142786187  |a Kox, Corinne  |m 142786187:Kox, Corinne  |p 3 
998 |g 13397121X  |a Bandapalli, Obul Reddy  |m 13397121X:Bandapalli, Obul Reddy  |d 910000  |d 910500  |e 910000PB13397121X  |e 910500PB13397121X  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1736893807  |e 3788321881 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia","title":"NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia"}],"language":["eng"],"recId":"1736893807","origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1736893807"],"doi":["10.3324/haematol.2012.073585"]},"physDesc":[{"extent":"9 S."}],"note":["Gesehen am 28.10.2020"],"relHost":[{"recId":"48524375X","origin":[{"dateIssuedKey":"2005","publisher":"Ferrata Storti Foundation","dateIssuedDisp":"2005-2013","publisherPlace":"Pavia"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 27.09.2018"],"disp":"NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemiaHaematologica, the hematology journal","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2186022-1"],"issn":["1592-8721"],"eki":["48524375X"]},"part":{"volume":"98","text":"98(2013), 6, Seite 928-936","year":"2013","pages":"928-936","extent":"9","issue":"6"},"language":["eng"],"title":[{"title_sort":"Haematologica, the hematology journal","subtitle":"official organ of the European Hematology Association","title":"Haematologica, the hematology journal"}],"pubHistory":["90.2005 - 98.2013"]}],"name":{"displayForm":["Obul R. Bandapalli, Martin Zimmermann, Corinne Kox, Martin Stanulla, Martin Schrappe, Wolf-Dieter Ludwig, Rolf Koehler, Martina U. Muckenthaler, and Andreas E. Kulozik"]},"person":[{"given":"Obul Reddy","role":"aut","display":"Bandapalli, Obul Reddy","family":"Bandapalli"},{"given":"Martin","role":"aut","display":"Zimmermann, Martin","family":"Zimmermann"},{"display":"Kox, Corinne","role":"aut","given":"Corinne","family":"Kox"},{"family":"Stanulla","role":"aut","given":"Martin","display":"Stanulla, Martin"},{"family":"Schrappe","display":"Schrappe, Martin","given":"Martin","role":"aut"},{"role":"aut","given":"Wolf-Dieter","display":"Ludwig, Wolf-Dieter","family":"Ludwig"},{"family":"Köhler","role":"aut","given":"Rolf","display":"Köhler, Rolf"},{"display":"Muckenthaler, Martina","role":"aut","given":"Martina","family":"Muckenthaler"},{"family":"Kulozik","display":"Kulozik, Andreas","given":"Andreas","role":"aut"}]} 
SRT |a BANDAPALLINOTCH1ACTI2013